Literature DB >> 16051276

Gastrointestinal hormone receptors in primary human colorectal carcinomas.

Celia Chao1, Marsha L Tallman, Kirk L Ives, Courtney M Townsend, Mark R Hellmich.   

Abstract

BACKGROUND: In this study, the prevalence and identity of the cells expressing functional receptors for the gastrointestinal (GI) peptide hormones: gastrin, bombesin, and neurotensin in dissociated cells from 20 freshly resected human primary colorectal carcinomas were determined.
MATERIALS AND METHODS: GI peptide hormone-induced increases in the concentration of free intracellular Ca(2+) ([Ca(2+)](i)) were used as an assay for the detection of functional receptors. Reverse-transcription polymerase chain reaction (RT-PCR) was performed in a subset of tumor samples. Agonist-responsive cells were identified as either of epithelial or stromal origin by immunocytochemistry with cytokeratin and vimentin antibodies, respectively.
RESULTS: Overall, expression of GI peptide hormone receptors was more frequent in stromal cells when compared to epithelial cells. Of the three receptors, expression of bombesin receptor (95%) was most prevalent in vimentin-positive (stromal) cells; whereas, gastrin receptor expression by cytokeratin-positive (epithelial) cells was more common (39%). A single gastrin receptor splice variant differentially regulates [Ca(2+)](i) in a cell-type specific manner. The gastrin receptor-expression profile in the 11 colon cancer-derived cell lines did not reflect the prevalence of expression in primary human cancers.
CONCLUSIONS: The Ca(2+) assay is a sensitive method for detecting functional GI peptide hormone receptor expression by colon cancer cells. Because this approach utilizes living cells, it is amenable to further functional analyses of signal transduction mechanisms at the single cell level. Importantly, our data provide a rationale for examining of the role of these GI peptide hormones and their cognate receptors in mesenchymal cell biology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051276     DOI: 10.1016/j.jss.2005.04.038

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  14 in total

1.  The neurotensin receptor-1 promotes tumor development in a sporadic but not an inflammation-associated mouse model of colon cancer.

Authors:  James M Bugni; Leina Al- Rabadi; Kevin Jubbal; Iordanis Karagiannides; Gregory Lawson; Charalabos Pothoulakis
Journal:  Int J Cancer       Date:  2011-11-17       Impact factor: 7.396

2.  Colorectal Cancer-Associated Fibroblasts are Genotypically Distinct.

Authors:  Amy A Mrazek; Joseph R Carmical; Thomas G Wood; Mark R Hellmich; Mahmoud Eltorky; Frederick J Bohanon; Celia Chao
Journal:  Curr Cancer Ther Rev       Date:  2014-01

3.  Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors.

Authors:  Kyriaki Bakirtzi; Maria Hatziapostolou; Iordanes Karagiannides; Christos Polytarchou; Savina Jaeger; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Gastroenterology       Date:  2011-07-30       Impact factor: 22.682

4.  Neurotensin-induced proinflammatory signaling in human colonocytes is regulated by β-arrestins and endothelin-converting enzyme-1-dependent endocytosis and resensitization of neurotensin receptor 1.

Authors:  Ivy Ka Man Law; Jane E Murphy; Kyriaki Bakirtzi; Nigel W Bunnett; Charalabos Pothoulakis
Journal:  J Biol Chem       Date:  2012-03-13       Impact factor: 5.157

5.  Suppression of neurotensin receptor type 1 expression and function by histone deacetylase inhibitors in human colorectal cancers.

Authors:  Xiaofu Wang; Lindsey N Jackson; Sara M Johnson; Qingding Wang; B Mark Evers
Journal:  Mol Cancer Ther       Date:  2010-07-27       Impact factor: 6.261

Review 6.  Gastrin, inflammation, and carcinogenesis.

Authors:  Celia Chao; Mark R Hellmich
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-02       Impact factor: 3.243

7.  CCK2 receptor expression transforms non-tumorigenic human NCM356 colonic epithelial cells into tumor forming cells.

Authors:  Celia Chao; Xueliang Han; Kirk Ives; Jeseong Park; Andrey A Kolokoltsov; Robert A Davey; Mary P Moyer; Mark R Hellmich
Journal:  Int J Cancer       Date:  2010-02-15       Impact factor: 7.396

Review 8.  Alternative splicing of pre-mRNA in cancer: focus on G protein-coupled peptide hormone receptors.

Authors:  Meike Körner; Laurence J Miller
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

9.  Design, synthesis, and characterization of novel apigenin analogues that suppress pancreatic stellate cell proliferation in vitro and associated pancreatic fibrosis in vivo.

Authors:  Haijun Chen; Amy A Mrazek; Xiaofu Wang; Chunyong Ding; Ye Ding; Laura J Porro; Huiling Liu; Celia Chao; Mark R Hellmich; Jia Zhou
Journal:  Bioorg Med Chem       Date:  2014-05-02       Impact factor: 3.641

10.  CCK(2) receptor splice variant with intron 4 retention in human gastrointestinal and lung tumours.

Authors:  Meike Körner; Beatrice Waser; Jean Claude Reubi; Laurence J Miller
Journal:  J Cell Mol Med       Date:  2009-07-20       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.